| Year |
Citation |
Score |
| 2019 |
Rodchenkov I, Babur O, Luna A, Aksoy BA, Wong JV, Fong D, Franz M, Siper MC, Cheung M, Wrana M, Mistry H, Mosier L, Dlin J, Wen Q, O'Callaghan C, et al. Pathway Commons 2019 Update: integration, analysis and exploration of pathway data. Nucleic Acids Research. PMID 31647099 DOI: 10.1093/Nar/Gkz946 |
0.745 |
|
| 2019 |
Vedanayagam J, Chatila WK, Aksoy BA, Majumdar S, Skanderup AJ, Demir E, Schultz N, Sander C, Lai EC. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis. Nature Communications. 10: 3682. PMID 31417090 DOI: 10.1038/S41467-019-11610-1 |
0.429 |
|
| 2018 |
Metz KS, Deoudes EM, Berginski ME, Jimenez-Ruiz I, Aksoy BA, Hammerbacher J, Gomez SM, Phanstiel DH. Coral: Clear and Customizable Visualization of Human Kinome Data. Cell Systems. PMID 30172842 DOI: 10.1016/J.Cels.2018.07.001 |
0.343 |
|
| 2018 |
Reznik E, Luna A, Aksoy BA, Liu EM, La K, Ostrovnaya I, Creighton CJ, Hakimi AA, Sander C. A Landscape of Metabolic Variation across Tumor Types. Cell Systems. PMID 29396322 DOI: 10.1016/J.Cels.2017.12.014 |
0.671 |
|
| 2017 |
Aksoy BA, Dancík V, Smith K, Mazerik JN, Ji Z, Gross B, Nikolova O, Jaber N, Califano A, Schreiber SL, Gerhard DS, Hermida LC, Jagu S, Sander C, Floratos A, et al. CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network. Database : the Journal of Biological Databases and Curation. 2017. PMID 29220450 DOI: 10.1093/Database/Bax054 |
0.512 |
|
| 2017 |
Snyder A, Nathanson T, Funt SA, Ahuja A, Buros Novik J, Hellmann MD, Chang E, Aksoy BA, Al-Ahmadie H, Yusko E, Vignali M, Benzeno S, Boyd M, Moran M, Iyer G, et al. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. Plos Medicine. 14: e1002309. PMID 28552987 DOI: 10.1371/Journal.Pmed.1002309 |
0.307 |
|
| 2016 |
Nathanson T, Ahuja A, Rubinsteyn A, Aksoy BA, Hellmann MD, Miao DD, Van Allen E, Merghoub T, Wolchok JD, Snyder A, Hammerbacher J. Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. Cancer Immunology Research. PMID 27956380 DOI: 10.1158/2326-6066.Cir-16-0019 |
0.311 |
|
| 2016 |
Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, et al. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell. 29: 104-116. PMID 26766592 DOI: 10.1016/J.Ccell.2015.12.004 |
0.633 |
|
| 2016 |
Cho S, Yoon C, Lee JH, Chang KK, Aksoy BA, Park DJ, Yoon SS. Abstract 893: Diffuse gastric adenocarcinoma often harborsKMT2Cmutations resulting in malignant phenotypes and worse overall survival Cancer Research. 76: 893-893. DOI: 10.1158/1538-7445.Am2016-893 |
0.341 |
|
| 2015 |
Miller ML, Reznik E, Gauthier NP, Aksoy BA, Korkut A, Gao J, Ciriello G, Schultz N, Sander C. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains. Cell Systems. 1: 197-209. PMID 27135912 DOI: 10.1016/J.Cels.2015.08.014 |
0.7 |
|
| 2015 |
Luna A, Babur Ö, Aksoy BA, Demir E, Sander C. PaxtoolsR: Pathway Analysis in R Using Pathway Commons. Bioinformatics (Oxford, England). PMID 26685306 DOI: 10.1093/Bioinformatics/Btv733 |
0.715 |
|
| 2015 |
Korkut A, Wang W, Demir E, Aksoy BA, Jing X, Molinelli EJ, Babur Ö, Bemis DL, Onur Sumer S, Solit DB, Pratilas CA, Sander C. Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells. Elife. 4. PMID 26284497 DOI: 10.7554/Elife.04640 |
0.719 |
|
| 2015 |
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, ... ... Aksoy BA, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121 |
0.367 |
|
| 2015 |
Sari M, Bahceci I, Dogrusoz U, Sumer SO, Aksoy BA, Babur Ö, Demir E. SBGNViz: A Tool for Visualization and Complexity Management of SBGN Process Description Maps. Plos One. 10: e0128985. PMID 26030594 DOI: 10.1371/Journal.Pone.0128985 |
0.693 |
|
| 2015 |
Babur Ö, Gönen M, Aksoy BA, Schultz N, Ciriello G, Sander C, Demir E. Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations. Genome Biology. 16: 45. PMID 25887147 DOI: 10.1186/S13059-015-0612-6 |
0.72 |
|
| 2015 |
Korkut A, Wang W, Demir E, Aksoy BA, Jing X, Molinelli EJ, Babur Ö, Bemis DL, Sumer SO, Solit DB, Pratilas CA, Sander C. Author response: Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells Elife. DOI: 10.7554/Elife.04640.031 |
0.636 |
|
| 2015 |
Yoon C, Cho S, Aksoy BA, Park DJ, Yoon SS. Abstract 4414: RhoA activation in diffuse type gastric adenocarcinoma promotes cancer stem cell phenotypes including chemotherapy resistance Cancer Research. 75: 4414-4414. DOI: 10.1158/1538-7445.Am2015-4414 |
0.302 |
|
| 2014 |
Babur Ö, Dogrusoz U, Çakır M, Aksoy BA, Schultz N, Sander C, Demir E. Integrating biological pathways and genomic profiles with ChiBE 2. Bmc Genomics. 15: 642. PMID 25086704 DOI: 10.1186/1471-2164-15-642 |
0.531 |
|
| 2014 |
Aksoy BA, Demir E, Babur Ö, Wang W, Jing X, Schultz N, Sander C. Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles. Bioinformatics (Oxford, England). 30: 2051-9. PMID 24665131 DOI: 10.1093/Bioinformatics/Btu164 |
0.557 |
|
| 2014 |
Babur Ö, Aksoy BA, Rodchenkov I, Sümer SO, Sander C, Demir E. Pattern search in BioPAX models. Bioinformatics (Oxford, England). 30: 139-40. PMID 24045775 DOI: 10.1093/Bioinformatics/Btt539 |
0.439 |
|
| 2014 |
Gao J, Aksoy BA, Gross B, Dresdner G, Sun Y, Sumer SO, Sander C, Schultz N. Abstract 4271: The cBioPortal for Cancer Genomics as a clinical decision support tool Cancer Research. 74: 4271-4271. DOI: 10.1158/1538-7445.Am2014-4271 |
0.488 |
|
| 2013 |
Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 45: 1127-33. PMID 24071851 DOI: 10.1038/Ng.2762 |
0.538 |
|
| 2013 |
Demir E, Babur O, Rodchenkov I, Aksoy BA, Fukuda KI, Gross B, Sümer OS, Bader GD, Sander C. Using biological pathway data with paxtools. Plos Computational Biology. 9: e1003194. PMID 24068901 DOI: 10.1371/Journal.Pcbi.1003194 |
0.732 |
|
| 2013 |
Aksoy BA, Gao J, Dresdner G, Wang W, Root A, Jing X, Cerami E, Sander C. PiHelper: an open source framework for drug-target and antibody-target data. Bioinformatics (Oxford, England). 29: 2071-2. PMID 23766416 DOI: 10.1093/Bioinformatics/Btt345 |
0.512 |
|
| 2013 |
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling. 6: pl1. PMID 23550210 DOI: 10.1126/scisignal.2004088 |
0.539 |
|
| 2013 |
Ciriello G, Cerami E, Aksoy BA, Sander C, Schultz N. Using MEMo to discover mutual exclusivity modules in cancer. Current Protocols in Bioinformatics / Editoral Board, Andreas D. Baxevanis ... [Et Al.]. Unit 8.17. PMID 23504936 DOI: 10.1002/0471250953.Bi0817S41 |
0.59 |
|
| 2013 |
Gao J, Sumer SO, Dresdner G, Aksoy BA, Sander C, Schultz N. Abstract 5140: Individual patient cancer profiles in the cBio Cancer Genomic Portal. Cancer Research. 73: 5140-5140. DOI: 10.1158/1538-7445.Am2013-5140 |
0.564 |
|
| 2012 |
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2: 401-4. PMID 22588877 DOI: 10.1158/2159-8290.Cd-12-0095 |
0.549 |
|
| Show low-probability matches. |